Europe Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies) and Treatment (Anti-Allergy Drugs and Immunotherapy)
Market Introduction
The allergies are hypersensitive responses from human immune system to the substance that come in contact with body. Severe allergy can be life threatening which disturb the normal functioning of organs such as asthma causes poor functioning of lungs. The most effective treatment for allergy is to avoid the known allergens, while there are medications such as steroids and antihistamines and other therapies which prevent allergies.
Get more information on this report :
Market Overview and Dynamics
The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments. However, the lack of awareness about allergy treatments restrains the market growth.
Key Market Segments
The Europe allergy treatment market, based on allergy type, is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, whereas the market for the food allergies segment is expected to grow at the fastest rate during the coming years.
The Europe allergy treatment market, based on treatment, is bifurcated into anti-allergy drugs and immunotherapy. In 2020, the anti-allergy drugs segment held a larger market share. However, the market for the immunotherapy segment is expected to grow at the fastest rate during the coming years.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Europe allergy treatment market are Allergy UK Organization (AUKO), European Academy of Allergy and Clinical Immunology (EAACI) and Spanish Society of Pneumology and Thoracic Surgery (SEPAR).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Europe allergy treatment market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe allergy treatment market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe allergy treatment market.
EUROPE ALLERGY TREATMENT MARKET SEGMENTATION
By Allergy Type:
- Eye Allergy
- Rhinitis
- Asthma
- Skin Allergy
- Food Allergies
- Other Allergies
By Treatment:
- Anti-Allergy Drugs
- Antihistamines
- Corticosteroids
- Decongestants
- Other Drugs
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-Lingual Immunotherapy (SLIT)
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- LETI Pharma
- Dermapharm Holding Se
- Johnson and Johnson Services, Inc.
- Sanofi
- AbbVie's Inc.
- Pfizer
- ALK-Abelló A/S
- Allergy Therapeutics
- Stallergenes Greer
- GlaxoSmithKline PLC
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Allergy Treatment Market – By Allergy Type
1.3.2 Allergy Treatment Market – By Treatment
1.3.3 Allergy Treatment Market – By Country
2. Allergy Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Allergy Treatment Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Expert Opinion
5. Allergy Treatment Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Immunotherapy in Allergy Treatment
5.1.2 Developments in Food Allergy Treatments
5.2 Key Market Restraints
5.2.1 Lack of Awareness About Allergy Treatments
5.3 Key Market Opportunities
5.3.1 Growing Number of Allergy-Related Research Projects and Programs
5.4 Future Trends
5.4.1 Development and Approvals of Innovative Medicines such as Biologics for Treating Allergies and Asthma
5.5 Impact Analysis
6. Allergy Treatment Market – Europe Analysis
6.1 Europe Allergy Treatment Marker Revenue Forecast and Analysis
7. Allergy Treatment Market Analysis– by Allergy Type
7.1 Overview
7.2 Allergy Treatment Market, by Allergy Type 2020 & 2028 (%)
7.3 Eye Allergy
7.3.1 Overview
7.3.2 Eye Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Rhinitis
7.4.1 Overview
7.4.2 Rhinitis: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Asthma
7.5.1 Overview
7.5.2 Asthma: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Skin Allergy
7.6.1 Overview
7.6.2 Skin Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Food Allergies
7.7.1 Overview
7.7.2 Food Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Other Allergies
7.8.1 Overview
7.8.2 Other Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Allergy Treatment Market Analysis– by Treatment
8.1 Overview
8.2 Allergy Treatment Market, by Treatment 2020 & 2028 (%)
8.3 Anti-Allergy Drugs
8.3.1 Overview
8.3.2 Anti-Allergy Drugs: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.3 Antihistamines
8.3.3.1 Overview
8.3.3.2 Antihistamines: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.4 Corticosteroids
8.3.4.1 Overview
8.3.4.2 Corticosteroids: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.5 Decongestants
8.3.5.1 Overview
8.3.5.2 Decongestants: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.6 Other Drug
8.3.6.1 Overview
8.3.6.2 Other Drug: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunotherapy
8.4.1 Overview
8.4.2 Immunotherapy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4.3 Sub-cutaneous Immunotherapy (SCIT)
8.4.3.1 Overview
8.4.3.2 Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4.4 Sub-Lingual Immunotherapy (SLIT)
8.4.4.1 Overview
8.4.4.2 Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. Allergy Treatment Market – Europe Analysis
9.1 Europe: Allergy Treatment Market
9.1.1 Overview
9.1.2 Europe: Allergy Treatment Market, by Country, 2020 & 2028 (%)
9.1.3 Germany: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 Germany: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2 Germany: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.3.3 Germany: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.3.3.1 Germany: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.3.3.2 Germany: Allergy Treatment Market, by Immunotherapy 2019–2028 (USD Million)
9.1.4 UK: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.1 UK: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.2 UK: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.4.3 UK: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.4.3.1 UK: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.4.3.2 UK: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.5 France: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1 France: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2 France: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.5.3 France: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.5.3.1 France: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.5.3.2 France: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.6 Italy: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 Italy: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 Italy: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.6.3 Italy: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.6.3.1 Italy: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.6.3.2 Italy: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.7 Spain: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Spain: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Spain: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.7.3 Spain: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.7.3.1 Spain: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.7.3.2 Spain: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.8 Rest of Europe: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Rest of Europe: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Rest of Europe: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.8.3 Rest of Europe: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.8.3.1 Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.8.3.2 Rest of Europe: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Allergy Treatment Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Allergy Treatment Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Johnson and Johnson Services, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sanofi
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AbbVie Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 LETI Pharma
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ALK-Abelló A/S
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Allergy Therapeutics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Stallergenes Greer
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GlaxoSmithKline plc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Dermapharm Holding
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 9. France: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. France: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 11. France: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 12. France: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Italy: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 15. Italy: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Allergy Treatment Market
LIST OF FIGURES
Figure 1. Allergy Treatment Market Segmentation
Figure 2. Allergy Treatment Market – By Country
Figure 3. Allergy Treatment Market Overview
Figure 4. Rhinitis Segment Held Largest Share of Allergy Treatment Market by Allergy Type
Figure 5. Anti-Allergy Drugs Segment Held Largest Share of Allergy Treatment Market by Treatment
Figure 6. Europe Allergy Treatment Market – Leading Country Markets (US$ Million)
Figure 7. Europe: PEST Analysis
Figure 8. Expert Opinion
Figure 9. Allergy Treatment Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Allergy Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Allergy Treatment Market, by Allergy Type 2020 & 2028 (%)
Figure 12. Eye Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Rhinitis: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asthma: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Skin Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Food Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Other Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Allergy Treatment Market, by Treatment 2020 & 2028 (%)
Figure 19. Anti-Allergy Drugs: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Antihistamines: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Corticosteroids: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Decongestants: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Other Drug: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Immunotherapy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe: Allergy Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. Europe: Allergy Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. Germany: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. UK: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. France: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Italy: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Spain: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Europe: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic on Allergy Treatment Market in European Countries
The List of Companies - Europe Allergy Treatment Market
- LETI Pharma
- Dermapharm Holding Se
- Johnson and Johnson Services, Inc.
- Sanofi
- AbbVie's Inc.
- Pfizer
- ALK-Abelló A/S
- Allergy Therapeutics
- Stallergenes Greer
- GlaxoSmithKline PLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe allergy treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe allergy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.